• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

自体血冠状动脉内注射治疗与直接经皮冠状动脉介入治疗相关的急性冠状动脉综合征中的慢血流和无复流现象

Autologous blood injection intracoronary artery for treating slow-flow and no-reflow in acute coronary syndrome related to primary pci.

作者信息

Truong Hoai Lam, Nguyen Xuan Duy, Nguyen Duc Hung, Nguyen Tuan Long

机构信息

Tam Anh Hospital Hanoi Capital Vietnam.

出版信息

Clin Case Rep. 2022 Feb 23;10(2):e05328. doi: 10.1002/ccr3.5328. eCollection 2022 Feb.

DOI:10.1002/ccr3.5328
PMID:35228873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8864574/
Abstract

Slow-flow and no-reflow phenomenon are taken to sudden loss of coronary artery flow, typically after stenting or angioplasty in primary PCI. Otherwise conventional therapy, we report a technique, which autologous blood into intracoronary to supply oxygen and break process thrombosis results in successfully management no-reflow in primary PCI in ACS.

摘要

慢血流和无复流现象是指冠状动脉血流突然丧失，通常发生在急性心肌梗死直接经皮冠状动脉介入治疗（PCI）中的支架置入或血管成形术后。除了传统治疗方法外，我们报告了一种技术，即将自体血注入冠状动脉以提供氧气并打破血栓形成过程，从而成功处理急性冠状动脉综合征（ACS）直接PCI中的无复流情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02be/8864574/ada1f11b97fc/CCR3-10-e05328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02be/8864574/ada1f11b97fc/CCR3-10-e05328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02be/8864574/ada1f11b97fc/CCR3-10-e05328-g001.jpg

相似文献

1
Autologous blood injection intracoronary artery for treating slow-flow and no-reflow in acute coronary syndrome related to primary pci.自体血冠状动脉内注射治疗与直接经皮冠状动脉介入治疗相关的急性冠状动脉综合征中的慢血流和无复流现象
Clin Case Rep. 2022 Feb 23;10(2):e05328. doi: 10.1002/ccr3.5328. eCollection 2022 Feb.
2
Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients.冠状动脉内注射硝普钠对急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗期间血流恢复的影响。
Minerva Cardioangiol. 2017 Apr;65(2):111-118. doi: 10.23736/S0026-4725.16.04126-8. Epub 2016 Jun 1.
3
Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.尼可地尔预防直接经皮冠状动脉介入治疗中的无复流/慢复流现象
Indian Heart J. 2007 May-Jun;59(3):246-9.
4
[Effect of intra-coronary injection of anisodamine on the slow-reflow phenomenon in patients with acute myocardial infarction after percutaneous coronary intervention].冠状动脉内注射山莨菪碱对急性心肌梗死患者经皮冠状动脉介入术后慢血流现象的影响
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Apr;28(4):295-9.
5
[Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction].[血塞通冠脉内注射治疗ST段抬高型心肌梗死患者PCI术后慢血流现象的疗效]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Apr;30(4):348-51.
6
Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.急性心肌梗死直接冠状动脉介入治疗中冠状动脉内注射硝普钠治疗慢血流/无复流现象
Catheter Cardiovasc Interv. 2004 Oct;63(2):171-6. doi: 10.1002/ccd.20149.
7
Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome.动脉粥样硬化性冠状动脉病变的斑块粥样物可能导致急性冠状动脉综合征患者出现无复流现象。
Circulation. 2002 Sep 24;106(13):1672-7. doi: 10.1161/01.cir.0000030189.27175.4e.
8
Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.急性心肌梗死患者经皮冠状动脉介入治疗后冠脉内注射山莨菪碱对慢血流现象的影响
Chin Med J (Engl). 2007 Jul 20;120(14):1226-31.
9
A pilot study of perfusion balloon predilatation in conjunction with intracoronary nicorandil administration for acute coronary syndrome.一项关于灌注球囊预扩张联合冠状动脉内给予尼可地尔治疗急性冠状动脉综合征的初步研究。
Cardiovasc Interv Ther. 2025 Jan;40(1):45-56. doi: 10.1007/s12928-024-01034-0. Epub 2024 Aug 13.
10
Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.急性心肌梗死中梗死相关动脉的血管造影形态学特征及及时再灌注：慢血流和无再流现象的预测因素
Chest. 2002 Oct;122(4):1322-32. doi: 10.1378/chest.122.4.1322.

本文引用的文献

1
Correlates of the "No-Reflow" or "Slow-Flow" Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention.接受直接经皮冠状动脉介入治疗患者中“无复流”或“慢血流”现象的相关因素
J Tehran Heart Cent. 2018 Jul;13(3):108-114.
2
Systems Analysis of Thrombus Formation.血栓形成的系统分析
Circ Res. 2016 Apr 29;118(9):1348-62. doi: 10.1161/CIRCRESAHA.115.306824.
3
Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
冠状动脉内联合注射腺苷和硝普钠可逆转血管成形术中的慢血流/无复流现象：一种缺血预处理的临床情况。
Can J Physiol Pharmacol. 2007 Mar-Apr;85(3-4):476-82. doi: 10.1139/y07-013.
4
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).一项关于腺苷作为急性心肌梗死再灌注治疗辅助药物的随机、双盲、安慰剂对照多中心试验（AMISTAD-II）。
J Am Coll Cardiol. 2005 Jun 7;45(11):1775-80. doi: 10.1016/j.jacc.2005.02.061.